Joan Camprodon, MD, PHD

Position: Division Chief
Categories: Faculty

Dr. Camprodon is Chief of the Division of Neuropsychiatry and Neuromodulation and Director of the Laboratory for Neuropsychiatry and Neuromodulation at Massachusetts General Hospital, and Assistant Professor of Psychiatry at Harvard Medical School. Clinically, he is the founding director of the MGH Transcranial Magnetic Stimulation (TMS) clinical service, a member of the Psychiatric Neurosurgery Committee and an attending physician in the departments of Psychiatry (Neuropsychiatry) and Neurology (Cognitive and Behavioral Neurology). He is board-certified in Psychiatry and Behavioral Neurology-Neuropsychiatry. Dr. Camprodon’s practice focuses on Neuropsychiatry and Behavioral Neurology, working clinically across the Departments of Psychiatry and Neurology at MGH. Using an integrated clinical neuroscience model, he cares for patients with comorbid neurological and psychiatric disorders, or presenting with atypical syndromes including disordered cognition, behavior and/or emotion in the context of known or suspected brain pathology. Dr. Camprodon’s clinical and research work focuses on Interventional Neuromodulation, using traditional and novel brain stimulation techniques such as Transcranial Magnetic Stimulation (TMS), Transcranial Direct Current Stimulation (tDCS), Electroconvulsive Therapy (ECT), Vagus Nerve Stimulation (VNS) and Deep Brain Stimulation (DBS). Research in his laboratory uses multimodal combinations of neuroimaging and brain stimulation to investigate neural circuitry and plasticity in a translational manner. He is interested in understanding basic circuit properties of human neural networks and how maladaptive plastic changes lead to neuropsychiatric disorders. Critical efforts, central to his role as a clinician-scientist, are geared toward applying the paradigms and methods of basic systems neuroscience to develop high-impact clinical tools, identify targets for therapeutic action and design individualized image-guided neuromodulation treatments. Dr. Camprodon studied Philosophy and Medicine at the University of Barcelona. After a neuroimaging research fellowship in the Department of Neurology at the Humboldt University in Berlin (Germany), he moved to Boston to pursue a PhD in Neuroscience in the Department of Neurology at Beth Israel Deaconess Medical Center, and a Master’s in Public Health at the Harvard School of Public Health. After completing his scientific training, he continued his research as junior faculty in the Department of Neurology at Harvard, until he joined MGH to do a Psychiatry residency, be the chief resident of the MGH Psychiatric Consultation Service and complete a clinical fellowship in Behavioral Neurology and Neuropsychiatry.